Loading…
Characterization of a bioactive meroterpenoid isolated from the marine-derived fungus Talaromyces sp
A new meroterpenoid, taladrimanin A ( 1 ), was isolated from a marine-derived fungus Talaromyces sp. HM6-1–1, together with eleven biogenetically related compounds ( 2–12 ). A plausible biosynthetic pathway for the meroterpenoids ( 1–4 ) was proposed. The planar structure of 1 was assigned by HRESIM...
Saved in:
Published in: | Applied microbiology and biotechnology 2022-04, Vol.106 (8), p.2927-2935 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A new meroterpenoid, taladrimanin A (
1
), was isolated from a marine-derived fungus
Talaromyces
sp. HM6-1–1, together with eleven biogenetically related compounds (
2–12
). A plausible biosynthetic pathway for the meroterpenoids (
1–4
) was proposed. The planar structure of
1
was assigned by HRESIMS and NMR. Its relative configuration was established by quantum chemical NMR calculation of two possible isomers and analyzed by DP4 + method. Finally, X-ray diffraction unambiguously confirmed the relative configuration and revealed the absolute configuration of compound
1
.
2–12
were assigned by comparing their NMR data with those reported in the literature.
1
was the first drimane-type meroterpenoid with a C10 polyketide unit bearing an 8
R
-configuration. In the bioactive assay,
1
exhibited antitumor activity against gastric cancer cells MGC803 and MKN28; it also inhibited the colony formation and induced apoptosis in MGC803 cells both in a concentration-dependent manner. Additionally,
1
displayed selective antibacterial activity against
Staphylococcus aureus
6538P, and low activities towards strains of
Vibrio parahaemolyticus
and
Escherichia coli
in this study.
Key points
•
Twelve compounds were obtained from Talaromyces sp., including four meroterpenoids, one of which was new.
•
The new compound taladrimanin A (
1
) inhibits the growth of gastric cancer cells MGC803 and MKN28 as well as the pathogenic bacteria Staphylococcus aureus 6538P.
•
The biosynthetic pathway of the meroterpenoids was proposed. |
---|---|
ISSN: | 0175-7598 1432-0614 |
DOI: | 10.1007/s00253-022-11914-1 |